News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,512 Results
Type
Article (41714)
Company Profile (473)
Press Release (661325)
Section
Business (208443)
Career Advice (2010)
Deals (35953)
Drug Delivery (97)
Drug Development (83361)
Employer Resources (169)
FDA (16342)
Job Trends (15049)
News (352202)
Policy (32994)
Tag
Academia (2619)
Alliances (50707)
Alzheimer's disease (1302)
Approvals (16282)
Artificial intelligence (154)
Bankruptcy (361)
Best Places to Work (11782)
Biotechnology (355)
Breast cancer (193)
Cancer (1405)
Cardiovascular disease (117)
Career advice (1677)
Cell therapy (301)
Clinical research (66462)
Collaboration (508)
Compensation (263)
COVID-19 (2601)
C-suite (114)
Data (1413)
Diabetes (176)
Diagnostics (6229)
Earnings (86119)
Employer resources (147)
Events (113486)
Executive appointments (402)
FDA (17026)
Funding (447)
Gene therapy (213)
GLP-1 (633)
Government (4418)
Healthcare (19021)
Infectious disease (2693)
Inflammatory bowel disease (118)
Interviews (309)
IPO (16618)
Job creations (3696)
Job search strategy (1430)
Layoffs (445)
Legal (7936)
Lung cancer (202)
Lymphoma (100)
Manufacturing (214)
Medical device (13359)
Medtech (13364)
Mergers & acquisitions (19486)
Metabolic disorders (478)
Neuroscience (1642)
NextGen Class of 2024 (6738)
Non-profit (4537)
Northern California (1716)
Obesity (273)
Opinion (202)
Patents (118)
People (57820)
Phase I (20854)
Phase II (29337)
Phase III (21690)
Pipeline (523)
Postmarket research (2598)
Preclinical (8937)
Radiopharmaceuticals (252)
Rare diseases (278)
Real estate (5998)
Regulatory (22110)
Research institute (2405)
Resumes & cover letters (351)
Southern California (1490)
Startups (3747)
United States (15605)
Vaccines (580)
Weight loss (198)
Date
Last 7 days (599)
Last 30 days (2395)
Last 365 days (36254)
2024 (36088)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54923)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (203)
Asia (38666)
Australia (6432)
California (3917)
Canada (1458)
China (310)
Colorado (175)
Connecticut (187)
Europe (84334)
Florida (537)
Georgia (135)
Illinois (398)
Indiana (227)
Maryland (642)
Massachusetts (3094)
Michigan (174)
Minnesota (296)
New Jersey (1124)
New York (1098)
North Carolina (802)
Northern California (1716)
Ohio (148)
Pennsylvania (934)
South America (1105)
Southern California (1490)
Texas (563)
Utah (110)
Washington State (413)
703,512 Results for "vistagen therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vistagen to Present at the Stifel 2024 Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
November 5, 2024
·
6 min read
Biotech Bay
Vistagen to Present at the Jefferies Global Healthcare Conference
Vistagen today announced that company management will present and host one-on-one meetings during the Jefferies Global Healthcare Conference taking place June 5 and 6, 2024 in New York City.
May 29, 2024
·
1 min read
Biotech Bay
Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference
Vistagen today announced that it will present posters at the American Society of Clinical Psychopharmacology Conference in Miami Beach, Florida from May 28 to 31, 2024.
May 23, 2024
·
6 min read
Press Releases
Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update
November 7, 2024
·
12 min read
Business
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
Vistagen announced today that for the second consecutive year it has been recognized by Mental Health America (MHA) for its dedication to promoting mental health and well-being in the workplace.
June 27, 2024
·
5 min read
Business
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Vistagen (Nasdaq: VTGN), a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today reported financial results for its fiscal year ended March 31, 2024, and provided a corporate update.
June 11, 2024
·
14 min read
Biotech Bay
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Vistagen today announced that company management will present and host one-on-one meetings during the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14 and 15, 2024 in New York City.
May 7, 2024
·
1 min read
Biotech Bay
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Vistagen today announced that it will present posters detailing clinical trial data for fasedienol, an investigational pherine candidate in Phase 3 development for the acute treatment of social anxiety disorder (SAD).
April 9, 2024
·
6 min read
Press Releases
Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024
November 1, 2024
·
2 min read
1 of 70,352
Next
